Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973656 · ClinicalTrials.gov registry record · NA
Role of Acetaldehyde in the Development of Oral Cancer
A NA study of Fanconi Anemia and Oral Cavity Carcinoma, sponsored by Masonic Cancer Center, University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT05973656: Recruiting NA study of Fanconi Anemia and Oral Cavity Carcinoma, sponsored by Masonic Cancer Center, University of Minnesota.
NCT05973656 is a NA study of Fanconi Anemia and Oral Cavity Carcinoma that is actively recruiting participants, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 170 participants, below the 325-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973656, a NA study of Fanconi Anemia and Oral Cavity Carcinoma, is actively recruiting participants, sponsored by Masonic Cancer Center, University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.
Primary Outcome
Identify and quantify DNA adducts in the oral cells (mouthwash and cheek brush samples).
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- DRUG Alcohol
- PROCEDURE Breath Test
Study Locations (1)
Minnesota
- Masonic Cancer Center, University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-07-08 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT05973656 shows while recruiting
NCT05973656 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 325-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (48% lower).
The record links to 3 conditions, with Fanconi Anemia appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT05973656 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05973656 about?
NCT05973656 is a clinical study titled "Role of Acetaldehyde in the Development of Oral Cancer". This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash a...
What is the current status of trial NCT05973656?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2022-07-08. Estimated completion is 2027-09-30.
What conditions does trial NCT05973656 study?
This clinical trial studies the following conditions: Fanconi Anemia, Oral Cavity Carcinoma, Alcohol-Related Carcinoma.
What interventions are being tested in trial NCT05973656?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Alcohol (DRUG), Breath Test (PROCEDURE).
Who is sponsoring clinical trial NCT05973656?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973656 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fanconi Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05973656's enrollment target sits among peer trials
170 4th of 15 higher than 12 of 15 other Fanconi Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fanconi Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer
ACTIVE NOT RECRUITING · NA
-
Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia
COMPLETED · NA
-
Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine
COMPLETED · NA
-
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
RECRUITING · Phase 1
-
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
RECRUITING
-
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI